This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Randomized Double-blind Study

Marianne Eronen, MD; Anneli Kari, MD; Erkki Pesonen, MD; Mikko Hallman, MD, ScD

Am J Dis Child. 1993;147(2):187-192.

Abstract
• Objective.
—To determine whether antenatal dexamethasone sodium phosphate administration constricts the fetal ductus arteriosus or improves spontaneous closure of the ductus in premature infants.

Design.
—A randomized double-blind study.

Setting.
—University hospital of Helsinki, Finland.

Participants.
—Sixty-one pregnant women with threatened preterm delivery between 24 and 31.9 weeks' gestation and 57 of their offspring (28 in the dexamethasone and 29 in the placebo group), born at 24 to 34.9 weeks' gestation, were studied using Doppler echocardiography.

Interventions.
—None.

Measurements and Main Results.
—Between the dexamethasone and placebo groups, there were no significant differences in systolic or diastolic flow velocity values in the fetal ductus arteriosus. Of the 29 infants with respiratory distress syndrome, 26 (90%) had hemodynamically significant patent ductus arteriosus and received indomethacin sodium: 12 (92%) of 13 dexamethasone-treated infants and 14 (88%) of 16 placebo-treated infants. One placebotreated infant was ligated. Of the 28 infants without respiratory distress syndrome, only four (14%) had hemodynamically significant patent ductus arteriosus. In infants born at or before 30 weeks' gestation, spontaneous closure of the ductus occurred more frequently after administration of prenatal dexamethasone (in six of 17 infants; 35%) than placebo (in none of 10 infants; P<.05).

Conclusions.
—Our data indicate that antenatal dexamethasone administration had no constrictive effect on the ductus arteriosus of the fetus between 24 and 31 weeks' gestation. However, antenatal dexamethasone had a beneficial effect on ductal closure in very premature infants.

(AJDC. 1993;147:187-192)

Author Affiliations
From the Children's Hospital, and Department of Obstetrics and Gynecology, University of Helsinki, Finland (Drs Eronen, Kari, and Pesonen), and Department of Pediatrics, University of California, Irvine (Dr Hallman).

Footnotes
Accepted for publication September 30, 1992.

Reprint requests to the Division of Pediatric Cardiology, Children's Hospital, University of Helsinki, Stenbackinkatu 11, 00290 Helsinki, Finland (Dr Eronen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevalence of Spontaneous Closure of the Ductus Arteriosus in Neonates at a Birth Weight of 1000 Grams or Less
Koch et al.
Pediatrics 2006;117:1113-1121.
ABSTRACT | FULL TEXT  

Comparison of Two Strategies for Surfactant Prophylaxis in Very Premature Infants: A Multicenter Randomized Trial
Kendig et al.
Pediatrics 1998;101:1006-1012.
ABSTRACT | FULL TEXT  

The Pharmacology of the Ductus Arteriosus
Smith
Pharmacol. Rev. 1998;50:35-58.
ABSTRACT | FULL TEXT  

Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease in Preterm Infants With Respiratory Distress Syndrome: A Multicenter Clinical Trial
Yeh et al.
Pediatrics 1997;100:e3-e3.
ABSTRACT | FULL TEXT